@article{oai:nagoya.repo.nii.ac.jp:00024649,
 author = {Koyama, Hiroko and Ikenuma, Hiroshi and Toda, Hiroshi and Kondo, Goro and Hirano, Masaki and Kato, Masaya and Abe, Junichiro and Yamada, Takashi and Wakabayashi, Toshihiko and Ito, Kengo and Natsume, Atsushi and Suzuki, Masaaki},
 issue = {9},
 journal = {Bioorganic & Medicinal Chemistry Letters},
 month = {May},
 note = {O^6-Benzylguanine (O^6-BG) is a substrate of O^6-methylguanine-DNA methyltransferase (MGMT), which is involved in drug resistance of chemotherapy in the majority of glioblastoma multiform. For clinical diagnosis, it is hoped that the MGMT expression level could be determined by a noninvasive method to understand the detailed biological properties of MGMT-specific tumors. We synthesized 11C-labeled O^6-[(3-methyl)benzyl]guanine ([11C]mMeBG) as a positron emission tomography probe. Thus, a mixed amine-protected stannyl precursor, N9-(tert-butoxycarbonyl)-O^6-[3-(tributylstannyl)benzyl]-N2-(trifluoroacetyl)guanine, was subjected to rapid C-[11C]methylation under [11C]CH3I/[Pd2(dba)3]/P(o-CH3C6H4)3/CuCl/K2CO3 in NMP, followed by quick deprotection with LiOH/H2O, giving [11C]mMeBG with total radioactivity of 1.34 GBq and ≥99% radiochemical and chemical purities.},
 pages = {1892--1896},
 title = {Synthesis of PET probe O^6-[(3-[11C]methyl)benzyl]guanine by Pd^0-mediated rapid C-[11C]methylation toward imaging DNA repair protein O^6-methylguanine-DNA methyltransferase in glioblastoma},
 volume = {27},
 year = {2017}
}